More about

Cardiovascular Disorder

News
February 07, 2024
2 min read
Save

Impact of OSA on future cardiovascular events differs by BMI

Impact of OSA on future cardiovascular events differs by BMI

Among adults with acute coronary syndrome not classified as having obesity, obstructive sleep apnea raised the risk for major cardiovascular and cerebrovascular events, according to results published in CHEST.

News
August 09, 2023
2 min read
Save

Interventional stroke program not superior to standard care at 1 year

Interventional stroke program not superior to standard care at 1 year

No differences in incidence of vascular events were observed in adults with ischemic stroke who received interventional care compared with standard care 1 year after baseline assessment, data show.

News
June 19, 2023
2 min read
Save

Obesity medication use plummets after bariatric surgery; cardiovascular drug use rebounds

Obesity medication use plummets after bariatric surgery; cardiovascular drug use rebounds

Patients who underwent bariatric surgery for morbid obesity had a “substantial and long-lasting reduction” of lipid-lowering and antidiabetic medication use compared with patients who did not undergo surgery.

News
June 05, 2023
2 min read
Save

‘Disentangling’ disease, treatments and comorbidities can reduce mortality in RMDs

‘Disentangling’ disease, treatments and comorbidities can reduce mortality in RMDs

Managing comorbidities is critical to minimizing deaths in patients with rheumatic and musculoskeletal diseases, according to data presented at EULAR 2023 Congress.

News
March 15, 2023
2 min read
Save

Cardiac arrest occurs in one in 9,000 pregnant patients during hospital delivery

Cardiac arrest occurs in one in 9,000 pregnant patients during hospital delivery

Cardiac arrest occurred in about one in every 9,000 delivery hospitalizations from 2017 to 2019 in the United States, and about seven in 10 women survived the event, according to the results published in Annals of Internal Medicine.

News
November 28, 2022
2 min read
Save

‘No clear increased risk’ for CV events with tofacitinib in ORAL Surveillance post-hoc

‘No clear increased risk’ for CV events with tofacitinib in ORAL Surveillance post-hoc

PHILADELPHIA — There is “no clear increased risk” for major adverse cardiovascular events associated with tofacitinib, according to a post-hoc analysis of the ORAL Surveillance trial presented at ACR Convergence 2022.

News
October 17, 2022
1 min read
Save

Patients with intracerebral hemorrhage at greater risk for cardiovascular events

Patients with intracerebral hemorrhage at greater risk for cardiovascular events

Patients with stroke due to nontraumatic intracerebral hemorrhage had significantly higher rates of major adverse cardiovascular events, researchers reported in JAMA Network Open.

News
September 25, 2020
10 min read
Save

Getting to the heart of CAR T-cell therapy’s cardiovascular risks

Getting to the heart of CAR T-cell therapy’s cardiovascular risks

How much risk is too much? It depends on what is at stake.

News
January 16, 2020
3 min read
Save

2019: To close out a decade of progress, new ways of thinking about cardiology emerge

2019: To close out a decade of progress, new ways of thinking about cardiology emerge

This interesting year was a fitting conclusion to an exciting decade. The Top 10 Stories of the Year in cardiology, selected by the Cardiology Today Editorial Board, represent well the changing landscape in our field.

News
September 07, 2016
7 min read
Save

CV implications of newer obesity medications

CV implications of newer obesity medications

Obesity, recognized as a chronic medical condition, affects more than 30% of adults in the United States and directly contributes to increased risk for CVD.